High level surface expression of CXCR4 has been associated with inferior outcome in pediatric ALL.[23,24] In this study, we offer further evidence that CXCR4 is an important functional determinant of treatment response in pediatric ALL. This evidence concerns the gene CXCR4 and acute lymphoblastic leukemia.